Hinge Health says revenue increased 50% in first quarter — still no price range for IPO
Hims & Hers gives weak outlook but says more collaborations are coming
Trump signs order to boost domestic drug manufacturing as pharma tariffs loom
Function Health buys Ezra, launches full-body scan for a third of the price
Hims & Hers brings former Amazon executive into C-suite
From 'Cockroach Award' to the Big Board: Hinge Health's unlikely path to IPO
Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
